These included 12 adenocarcinomas, 9 squamous cell carcinomas and 1 large cell carcinoma, all examined for known EGFR/KRAS/NRAS/HRAS/PI3K mutations [15](Figure 1). The gene discussed is KRAS; the disease is squamous cell carcinoma.